Temporo-mandibular disorders, craniofacial pain, trigeminal neuralgia and muscular problems resulting from inflammation related to extractions, implant surgery and interventions on the canals of the tooth root and on the soft tissue are areas in which the MLS® Laser Therapy has already demonstrated its effectiveness. The results already obtained in the field have allowed ASAlaser to participate in the 98th edition of the TDA Congress in Bangkok organized by the Dental Association of Thailand, to launch officially its therapeutic proposal on the local market.
The stand of the Thai partner IMS / Dental Siam has hosted all the devices of the Mphi D line – from the portable Mphi D to the Mphi 5 D with multidiodic handpiece - developed by the company to enable the highest performing application of MLS® in the treatment of Temporo-mandibular disorders. «Our activity in the Thai market - explains Lucio Zaghetto, ASAlaser CEO – has begun five years ago and since then our position is progressively increased, thanks to the ever closer and tested cooperation with our local partner. A partnership that has allowed us to open ourselves to other challenges: the new one regards the dental sector, an area where we truly believe thanks to the confirmations received from other companies exhibiting at TDA Congress, to the feeling with the local partner and to the interest shown by visitors to the stand (as for example some doctors from important local universities. We are confident of repeating the positive trend had in the physiotherapy’s sector during the last five years». In this direction goes the choice of the company to take part in two other appointments in the dental industry that will be held in the country: the May edition of the TDA Congress and the FDI Congress, an international meeting scheduled for September. «On this occasion - concludes Zaghetto - ASAlaser will directly participate. An important step that we hope will be preceded by further encouraging feedback. I refer to those that we hope to raise during the IDS, the most important dental congress in the world scheduled in Germany in March».
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.